Ocular infection & inflammation pharmacology Flashcards
1
Q
Infection considerations
A
- barriers (skin & mucous membranes)
- Immune status
- organisms (bacteria, virus, fungi)
2
Q
Gram positive Cocci
A
- staph aureus
- staph epidermidis
- strep pneumonia
- strep pyogenes
- strep faecalis
3
Q
Gram negative Rods
A
- Haem Influenzae
- Pseudomonas aeruginosa
- Serratia Marcescens
4
Q
Gram negative Cocci
A
- Neisseria gonorrhoeae
5
Q
Bacteria def
A
- single celled
- subdivided by shape and gram stain
6
Q
Gram Stain
A
- pos = violet = thick peptidoglycan layer in cell wall
- neg = red = thinner petidoglycan layer
7
Q
unique structural bacteria
A
- Rickettsia (gram - found in ticks, fleas & mammals)(zoonotic)
- Chlamydia (mimic virus)
- Treponema palladium (syphilis - the masqarader)
- Mycobaterium tuberculosos
- Actinomyces (anaerobic - resemble fungal hyphae)
8
Q
Bact uniqueness
A
- Peptidoglycan Cell wall (penicillin vulnerability)
- Ribosome cell membrane
9
Q
Bactericidal
A
- destroys cell wall - peptidoglycan - Penicillin
10
Q
Bacteriostatic
A
- inhibit cell growth - Tetracycline
11
Q
Selective toxicity
Bact vs human
A
- Bact has cell walls - antibacterial inhibits synthesis of cell wall
- Cell membranes are similar
- Ribosomes - diff size and composition
- inhibit bact protein synthesis
12
Q
Selective toxicity
Drugs
A
- biosynthetic pathways (intermediary metabolism)(Folic acid - bact produce/synthesize)
- Enzyme DNA gyrasee (prevents supercoiling of DNA during replication & transcription)
13
Q
Mechanisms of Resistance
A
- Bact produces enzymes that degrade/inactivate antibiotics
- pump mechanisms (pump out) or decrease permeability of antibiotics
- resistance genes
- alteration for bact ribosomes
- chromosomal mutation
14
Q
Cross resistance
A
- Misuse/overuse/non-compliance - SYSTEMIC mostly
- excess from animal feed
- leads to resistance to similar groups of antibiotics
- penicillin vs cephalosporins (similar drug structure)
15
Q
Indications for oral antibiotics
A
- Meibomianitis
- Internal Hordeolum
- Ocular Rosacea
- Dacryocystitis
- Preseptal Cellulitis
- Chlamydial Conj
- Prophylaxis (fractures, sinusitis)
16
Q
Topical Anti-biotics Use
A
- Ant Segment infection
- Conjunctivitis
- Corneal Ulcer
- Blepharitis
- Prophylaxis
17
Q
Drug considerations
A
- selective toxicity
- spectrum of activity (narrow vs broad)
- resistance
18
Q
Guideline for effective therapy
A
- accurate dx
- microorganism sensitivity to anti-infective
- least toxic drug
- adequate drug level
- optimum route of admin
- appropriate dosage
- appropriate tx time
- augment with physical procedures
19
Q
Antimicrobial Failure - why?
A
- inaccurate Dx
- resistance (drug)
- inadequate dosage
- noncompliance
- inadequate suppl physical procedures
- inadequate immune system response
20
Q
Drugs affecting Cell Wall
A
- Penicillins
- Cephalosporin
- Vancomycin
- Bacitracin (ung)
21
Q
Vancomycin
A
-think = last line for MERSA
22
Q
Chloramphenicol
A
- think = aplastic anemia
23
Q
Penicillins
A
- Augmentin (Amoxicillin + clavulanate)
- Dicloxacillin
24
Q
Cephalosporins
A
- Cephalexin (Keflex)
- Cefaclor (Ceclor)
25
B-Lactam antibiotics
- Penicillins & Cephalosporins
- B-lactam ring (similarity)
- resistant bact produces enzyme to disrupt B-lactam ring
26
Penicillins use
| systemic
- Hordeolum
- Preseptal cellulitis
- Dacryocystitis
- Dacryoadenitis
27
Penicillin adverse reaction
- Hypersensitivity response (type 1 - 4) (2%)
- GI irritation (nausea, vomit, diarrhea)
- diarrhea is common - kills normal flora
- Superinfection (Tx but gets worse)
28
Penicillin vs Cephalosporin
- if Penicillin hypersensitive less than 2% cross-react to cephalosporin
- less likely in 3rd + 4th gen Cepalos
29
```
clavulanate mechanism
(Augmentin)
```
- B-Lactamase inhibitor
- protects penicillin from penicillanse
- weak anti-microbial activity
30
Cephalosporins
- B-lactam ring (similar to Penicillin)
- addition of acyl side chains (1-4 gen)
- Broad spectrum
- Bactericidal
- Resistance (B-lactamase)
31
Cephalosporin Use
- same as Penicillins
| - other (ophthalmically fortified use)
32
Bacitracin
- Gram +
- Bactericidal
- Ointment (unstable in sol)
- Combo = Polycin (Bacitracin + Polymyxin B)(for Gram - )
- Blepharitis
- Dose - QD > TID
33
Vancomycin
| cell wall destroyer
- highly active for gram +
- Bactericidal
- Dosage - Sol-inject, capsule, powder for fort
- Highly toxic - anaphylaxis, vasculitis, nephrotoxic, ototoxic (delayed), neutropenia, more
34
Vancomycin use
- Bact endopthalmitis
- Methicilin/Penicillin resistant infections
- Bact Keratitis - vision threat
- Ruptured globe
- Orbital cellulites
35
Cytoplasmic Membrane affectors
- Polymyxin B
- Gramicidin
- disrupts cell membrane permeability
36
Polymyxin B
- disrupts cell osmotic integrity
- bactericidal
- Gram - (pseudomonas)
- use - conj & lid infects
-
37
Polymyxin B combos
- Polymyxin B/Neomycin/Gramcidin (generic)
-Polymyxin B/Trimethoprim (Polytrim)
- Polymyxin B/Bacitracin (Polycin)
- Polymyxin B/Bacitracin/Neomycin (Neo-Polycin)
with Steroids:
Polymyxin B/bacitracin/neomycin/hydrocortison (generic)
38
Gramicidin
- Bactericidal (with static act)
- Gram +
- Combo = Neosporin
Polymyxin B/Neomycin/Gramicidin
39
AntiBact affecting Protein Synthesis
- Aminoglycosides
- Macrolides
- Tetracyclines
- Chloramphenicol
- Clindamycin
40
Aminoglycosides
| Ocular - mostly topical
- Neomycin
- Gentamicin
- Tobramycin
- Amikacin
- inhibit bact protein synthesis by binding to ribosome (30s subunit)
- bactericidal
- gram + & -
41
Macrolides
- Erythromycin
- Azithromycin (chlamydia*)
- Clarithromycin
42
Tetracyclines
- Tetracycline
- Doxycycline
- Minocycline
43
Neomycin
- Broadspectrum gram +& -
- ineffective against P.aeruginosa
- Combo's
- ADR = contact dermatitis
44
Gentamicin
- broad spect - better with P.Aeruginosa
- not effective Streptococcus
- Use - Ant seg infections
- ADR - cornea & conj tox & allergy (less than neomycin)
- Dose - sol/ung - q4h
45
Tobramycin (best choice)
- broad spec c Pseudomonas
- similar to Gentamicin except:
* sensitive to gentamicin resistant pseudomonas strains
* more potent with P. aeruginosa
- Use - ant seg inf
- Combo with dexamethasone (Tobradex)(HSV worse!)
- ADR's - less than other Aminoglycosides
46
Tetracyclines
| also anti-inflam effects!
- Block protein synthesis & bacteriostatic
- Broad spec +&- & chlamydia
- S.aureus resistance
- short, intermediate, long acting
- topical = Trachoma
47
Tetracycline Oral use
- Chlamydia (inclusion conj + trachoma)
- Acne rosacea, Meibomianitis
- Nontuberculous phlyctenular keratoconjunctivitis
- noninfected corneal ulcers (relates to anticollagenolytic action or oral tetra)
48
lateral canthus bubbles (sign)
- sign of free fatty acids
- bact in sebum
- bact releasing lipases increase free fatty acids
- irritation & inflammation
- Meibomianitis!
49
Tetracycline Topical use
- gonococcal ophthalmia neonatum (prophylaxis)
| - trachoma
50
Tetracycline (class) considerations
- absorption affected by:
* food (not doxy)
* iron containing tonics
* antacids containing Ca, Mg or Alu
* Sodium Bicarbonate
- when use restrict:
Antacids, iron, zinc, dairy, vit/mineral preps
51
Tetracyclines ADR's
- Hypersensitivity reactions
- Anaphylaxis, urticaria, rash, periorbital edema
- Photosensitivity/photo toxic
- GI irritation (better with food but reduced absorption)
- Epigastric distress (sore throat/ glossitis
- tooth development (staining, caries, dysgensis & discolor)(under 8 yrs)
- depress bone growth (attracted to embryonic & bone growing tissue)
- pseudotumor cerebri !! watch teenagers!!
- blood dyscrasias (watch blood thinners-coumadin)
- vestibular toxicity (minocycline)(tinnitus, dizzy)
52
Tetracycline Contra
- pregnancy (CatD)
- okay short term during breast feeding
- no kids under 8 yrs
53
Tetracycline (generic) Uses
- Chlamydia
- Acne Rosacea
- Meibomianitis
- Resistant sebaceous blepharitis
* accumulate in Sebaceous Glands
* resistance can be a problem
54
Doxycycline uses
- best choice for Chlamydia/acne rosacea
- Meibomianitis
- Ocular surface inflammatory disease
55
Tetracyline Ophthalmic
- not used in US
| - replaced by erytrhomycin ophth ung
56
Doxycycline dosage
- 100mg BID (1-2 wks then taper), maintenance PRN (20-100mg daily or less)
- Oracea (imm & sustained release) = 40mg QD am's empty tummy
57
Macrolides Pharmacology
- binds to 50S ribosomal subunit - inhibits protein synthesis
- low toxicity
- Bacteriostatic
- spectrum can include:
* gram - & +
* streptococci
* staphylococci
* Chlamydia
* Neiserria
* H influenzae
58
Macrolides clinical use
- chlamydial infections
| - sebaceous gland dysfunction
59
Erythromycin
- oral & topical
- Cat B - safer for pregnant, nursing & kids under 8
- ung only
- ADR's = mild
- Uses:
* lid infection
* prophyl ophth neonatorum
* Gonococcal conj
* Chlamydial inf
60
Azithromycin (Zithromax)
Oral - single dose 1000mg
Extended half life > QD
- semisynthetic derivate of erythro
- Cat B
- ADR - skin rash/GI upset
- Uses:
* Chlamydia
* gono conj
* ocular rosacea
61
Azithromycin 1% Ophthalmic
| AzaSite
- Durasite-vehicle
- Growing resistance
- useful for trachoma not chlamydia
62
anti-inflammatory efffect of anti-biotics
- anti-inflammatory effect helps control bacterial colonization and lid inflammation
- Doxy treats MGD via antimicrobial, anti-inflamm and antimetalloproteinase prop
- Azithro inhibits pro-inflamm cytokines
- 5 day oral Azithro was better than doxy for MGD - better signs, shorter tx
63
Trachoma
```
Oral
- Azithromycin drug of choice
*children 20mg/kg single dose
* adult 1g single dose
- Erythormycin = Alt Tx
* children 30-50mg/Kg/day Q6H x 7days
* adult 250mg q6h x 2wks
Doxy = Alt Tx
100mg BID x 3 wks
```
Topical
Tetra or erythro ung BID-QID x 3-6wks
Cochrane favours oral Azithro to topical Tetra
64
Chloramphenicol
- binds to 50s ribosomal subunit
- Bacteriostatic (some bactericidal act)
- broad spectrum (P.Aer resistant)
- Chlamydia
- Bacillus anthracis - anthrax (systemic)
- systemic risk for APLASTIC ANEMIA (watch infants on topical) - not dose dependent
- Avail topical, oral, IV or IM
65
Antibacterials Affecting Folic Acid
- Sulfonamides
- Pyrimethamine
- Trimethoprim
66
Sulfonamides
- Broad spectrum
- also Chlamydia & Toxoplasma (great systemic)
- Resistance: Staph & Pseudomonas
- Mainly used orally - Topically too much resistance
- Inactivated by PABA (local anesthetics - procaine, teracaine - esters of PABA
- Inhibited by blood, pus - purulent exudates contain PABA
- Bacteriostatic
67
Topical Sulfonamide - Sulfacetamide (Bleph10)
- sol or ung
- broad spec
- resistance++ not useful : (
68
Trimethoprim
- Use - surface ocular infection
- typical combo with Polymixin B (Polytrim)
- gram +&- (not pseudomonas)
- approved for infants 2mths and older
- ADR's mild
- great for kids
69
Antibiotics affect DNA synthesis - Fluoroquinolones
- interferes with DNA synthesis during replication
- inhibits DNA gyrase - inability to unwind DNA helix for replication
- results in cell death and ability to replicate
- resistance is forming
70
Fluoroquinolones Topical Uses
- conj
- Keratitis
- Corneal ulcer
- pre/post Sx
71
Fluoroquinolones Systemic Uses
- UTI
- GI
- Respiratory & skin infections
72
Fluoroquinolones resistance
- reduced cellular accumulation - decrease passive transport into cell & Efflux pumps
- Single step mutation - bact alter DNA gyrase
- Ciprofloxacin - 10% resistant S. pneumo
- increasing MRRSA
73
Fluoroquinolones family
- Norfloxacin
- Ofloxacin
- Ciprofloxacin
- Levofloxacin
- Gatifloxacin
- Moxifloxacin
- Besifloxacin (ocular only)
74
Fluoroquinolones systemic ADR's
```
Common
- GI upset
- CNS (HA & dizzy)
Uncommon
- tendon rupture
- prolongation of QT interval
- Arthroplasty
- hepatitis
- POSSIBLE RD's
```
75
2nd gen Fluoroquinolones
- Nor, Cipro, Oflox
- better activity to common paths than:
* Aminoglycosides
* Chloramphenicol
* Tetracycline
* Erythromycin
- coneal precipitates with Cipro - goes away with discont
76
3rd gen Fluoroquinolones
- maintained excellent gram- cover with improved gram+ cover
- less resistance
- ineffective if cipro/oflox resistance
- levoflox 0.5% & 1.5%
- superior to 2nd gen esp Streptococcus
77
4th gen Fluoroquinolones
- 2 mutations required for resistence
- Gati 0.3%/0.5%
- Moxi 0.5%
- Besi 0.6%
78
Moxifloxacin 0.5%
- bact conj
- no preservative
- peds use (4mths +)
- xanthum gum vehicle (better staying power)
- Cat C
- Dose 1 gtt BID x 7days
79
Gatifloxacin 0.5%
- bact conj
| - Q2H day 1; BID - QID day 2-7
80
Besifloxacin 0.6%
- bact conj
- SUSPENSION
- DuraSite delivery system
- broad spectrum
- Cat C
- 1yr old +
81
Considerations for Oral Antibiotics
- Probiotics add in
- food = yoghurt, sauerkraut, kimchi
- do not take with anti - after
- caution px on chemo/compromised immune & proton inhibitors
82
Antibiotics and contraceptives
- possible but not proven
- 13 fold risk - enzyme-inducing drugs - carbazapine, topiramate, rifampicin
- 7 fold risk in antibiotics general